BIIB Financial Statements

Balance sheet, income statement, cash flow, and dividends for Biogen Inc (BIIB).


$22.28B Market Cap.

As of 02/12/2025 5:00 PM ET (MRY) • Disclaimer

BIIB Market Cap. (MRY)


BIIB Shares Outstanding (MRY)


BIIB Assets (MRY)


Total Assets

$28.05B

Total Liabilities

$11.33B

Total Investments

$560.50M

BIIB Income (MRY)


Revenue

$9.68B

Net Income

$1.63B

Operating Expense

$5.46B

BIIB Cash Flow (MRY)


CF Operations

$2.88B

CF Investing

-$799.20M

CF Financing

-$683.50M

BIIB Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

BIIB Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$28,049,300,000 (4.49%)

$26,844,800,000 (9.33%)

$24,554,100,000 (2.83%)

$23,877,300,000 (-3.01%)

Assets Current

$7,456,800,000 (8.71%)

$6,859,300,000 (-29.94%)

$9,791,200,000 (24.63%)

$7,856,500,000 (14.08%)

Assets Non-Current

$20,592,500,000 (3.04%)

$19,985,500,000 (35.38%)

$14,762,900,000 (-7.85%)

$16,020,800,000 (-9.65%)

Goodwill & Intangible Assets

$16,170,100,000 (10.89%)

$14,582,200,000 (91.89%)

$7,599,100,000 (-4.80%)

$7,982,400,000 (-9.77%)

Shareholders Equity

$16,716,000,000 (12.95%)

$14,799,400,000 (10.46%)

$13,397,900,000 (22.96%)

$10,896,200,000 (1.83%)

Property Plant & Equipment Net

$3,537,700,000 (-5.15%)

$3,729,700,000 (0.73%)

$3,702,500,000 (-2.36%)

$3,791,800,000 (-1.38%)

Cash & Equivalents

$2,375,000,000 (126.21%)

$1,049,900,000 (-69.29%)

$3,419,300,000 (51.20%)

$2,261,400,000 (69.88%)

Accumulated Other Comprehensive Income

-$136,200,000 (11.39%)

-$153,700,000 (6.79%)

-$164,900,000 (-54.55%)

-$106,700,000 (64.31%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$560,500,000 (-24.77%)

$745,000,000 (-79.91%)

$3,708,400,000 (-15.19%)

$4,372,600,000 (-11.66%)

Investments Current

$0 (0%)

$0 (0%)

$1,473,500,000 (-4.39%)

$1,541,100,000 (20.50%)

Investments Non-Current

$560,500,000 (-24.77%)

$745,000,000 (-66.67%)

$2,234,900,000 (-21.07%)

$2,831,500,000 (-22.87%)

Inventory

$2,460,500,000 (-2.65%)

$2,527,400,000 (87.99%)

$1,344,400,000 (-0.53%)

$1,351,500,000 (26.47%)

Trade & Non-Trade Receivables

$1,868,800,000 (-11.01%)

$2,100,000,000 (-1.70%)

$2,136,400,000 (8.91%)

$1,961,700,000 (-15.71%)

Trade & Non-Trade Payables

$424,200,000 (5.18%)

$403,300,000 (-17.95%)

$491,500,000 (-16.58%)

$589,200,000 (29.52%)

Accumulated Retained Earnings (Deficit)

$19,259,800,000 (9.26%)

$17,627,600,000 (7.05%)

$16,466,500,000 (18.36%)

$13,911,700,000 (-0.46%)

Tax Assets

$324,200,000 (-65.09%)

$928,600,000 (-24.28%)

$1,226,400,000 (-13.33%)

$1,415,100,000 (3.33%)

Tax Liabilities

$738,800,000 (-17.84%)

$899,200,000 (51.23%)

$594,600,000 (-31.59%)

$869,200,000 (-26.01%)

Total Debt

$6,630,300,000 (-9.65%)

$7,338,200,000 (10.95%)

$6,614,000,000 (-13.01%)

$7,603,500,000 (-2.87%)

Debt Current

$1,748,600,000 (1065.73%)

$150,000,000 (0%)

$0 (0%)

$999,100,000 (0%)

Debt Non-Current

$4,881,700,000 (-32.09%)

$7,188,200,000 (8.68%)

$6,614,000,000 (0.15%)

$6,604,400,000 (-15.63%)

Total Liabilities

$11,333,300,000 (-5.91%)

$12,045,400,000 (7.88%)

$11,165,700,000 (-13.56%)

$12,917,600,000 (-7.29%)

Liabilities Current

$5,528,800,000 (60.99%)

$3,434,300,000 (4.93%)

$3,272,800,000 (-23.86%)

$4,298,200,000 (14.86%)

Liabilities Non-Current

$5,804,500,000 (-32.59%)

$8,611,100,000 (9.10%)

$7,892,900,000 (-8.43%)

$8,619,400,000 (-15.42%)

BIIB Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$9,675,900,000 (-1.62%)

$9,835,600,000 (-3.32%)

$10,173,400,000 (-7.36%)

$10,981,700,000 (-18.32%)

Cost of Revenue

$2,310,400,000 (-8.80%)

$2,533,400,000 (11.20%)

$2,278,300,000 (7.99%)

$2,109,700,000 (16.87%)

Selling General & Administrative Expense

$2,403,700,000 (-5.73%)

$2,549,700,000 (6.08%)

$2,403,600,000 (-10.12%)

$2,674,300,000 (6.78%)

Research & Development Expense

$2,041,800,000 (-17.07%)

$2,462,000,000 (10.35%)

$2,231,100,000 (-10.80%)

$2,501,200,000 (-37.33%)

Operating Expenses

$5,459,500,000 (-9.09%)

$6,005,400,000 (39.55%)

$4,303,300,000 (-39.62%)

$7,126,800,000 (8.11%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$273,800,000 (102.37%)

$135,300,000 (-78.62%)

$632,800,000 (1105.33%)

$52,500,000 (-94.71%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

$1,632,200,000 (40.53%)

$1,161,500,000 (-60.78%)

$2,961,600,000 (71.43%)

$1,727,600,000 (-57.45%)

Net Income to Non-Controlling Interests

$0 (0%)

$400,000 (100.47%)

-$85,300,000 (-149.74%)

$171,500,000 (186.31%)

Net Income

$1,632,200,000 (40.57%)

$1,161,100,000 (-61.89%)

$3,046,900,000 (95.80%)

$1,556,100,000 (-61.10%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

$1,632,200,000 (40.57%)

$1,161,100,000 (-61.89%)

$3,046,900,000 (95.80%)

$1,556,100,000 (-61.10%)

Weighted Average Shares

$145,600,000 (0.62%)

$144,700,000 (-0.41%)

$145,300,000 (-2.55%)

$149,100,000 (-7.33%)

Weighted Average Shares Diluted

$145,900,000 (0.21%)

$145,600,000 (-0.27%)

$146,000,000 (-2.41%)

$149,600,000 (-7.25%)

Earning Before Interest & Taxes (EBIT)

$1,906,000,000 (47.02%)

$1,296,400,000 (-64.77%)

$3,679,700,000 (128.75%)

$1,608,600,000 (-67.78%)

Gross Profit

$7,365,500,000 (0.87%)

$7,302,200,000 (-7.51%)

$7,895,100,000 (-11.01%)

$8,872,000,000 (-23.78%)

Operating Income

$1,906,000,000 (46.98%)

$1,296,800,000 (-63.90%)

$3,591,800,000 (105.81%)

$1,745,200,000 (-65.42%)

BIIB Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$799,200,000 (80.51%)

-$4,101,000,000 (-360.12%)

$1,576,600,000 (379.69%)

-$563,700,000 (7.38%)

Net Cash Flow from Financing

-$683,500,000 (-557.80%)

$149,300,000 (108.54%)

-$1,747,300,000 (16.24%)

-$2,086,200,000 (60.43%)

Net Cash Flow from Operations

$2,875,500,000 (85.85%)

$1,547,200,000 (11.77%)

$1,384,300,000 (-61.97%)

$3,639,900,000 (-13.95%)

Net Cash Flow / Change in Cash & Cash Equivalents

$1,392,800,000 (157.92%)

-$2,404,500,000 (-298.13%)

$1,213,600,000 (22.59%)

$990,000,000 (159.95%)

Net Cash Flow - Business Acquisitions and Disposals

-$668,000,000 (89.12%)

-$6,138,000,000 (-719.81%)

$990,300,000 (3424.20%)

$28,100,000 (102.79%)

Net Cash Flow - Investment Acquisitions and Disposals

$144,700,000 (-93.87%)

$2,359,700,000 (960.54%)

$222,500,000 (171.82%)

-$309,800,000 (-131.72%)

Capital Expenditure

-$271,200,000 (12.91%)

-$311,400,000 (-191.75%)

$339,400,000 (222.57%)

-$276,900,000 (41.93%)

Issuance (Repayment) of Debt Securities

-$650,000,000 (-447.04%)

$187,300,000 (118.69%)

-$1,002,200,000 (-489.53%)

-$170,000,000 (-111.59%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$0 (0%)

-$750,000,000 (58.33%)

-$1,800,000,000 (73.05%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

-$67,700,000 (-292.88%)

$35,100,000 (163.02%)

-$55,700,000 (6.86%)

-$59,800,000 (-186.67%)

Share Based Compensation

$291,200,000 (10.22%)

$264,200,000 (3.97%)

$254,100,000 (6.50%)

$238,600,000 (20.32%)

Depreciation Amortization & Accretion

$733,400,000 (48.22%)

$494,800,000 (-22.45%)

$638,000,000 (-42.88%)

$1,117,000,000 (67.49%)

BIIB Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

76.10% (2.56%)

74.20% (-4.38%)

77.60% (-3.96%)

80.80% (-6.70%)

Profit Margin

16.90% (43.22%)

11.80% (-60.54%)

29.90% (110.56%)

14.20% (-52.35%)

EBITDA Margin

27.30% (50.00%)

18.20% (-57.08%)

42.40% (70.97%)

24.80% (-41.09%)

Return on Average Equity (ROAE)

10.20% (25.93%)

8.10% (-67.21%)

24.70% (69.18%)

14.60% (-58.64%)

Return on Average Assets (ROAA)

5.90% (34.09%)

4.40% (-64.52%)

12.40% (90.77%)

6.50% (-58.86%)

Return on Sales (ROS)

19.70% (49.24%)

13.20% (-63.54%)

36.20% (147.95%)

14.60% (-60.65%)

Return on Invested Capital (ROIC)

15.00% (89.87%)

7.90% (-63.59%)

21.70% (141.11%)

9.00% (-68.20%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

13.64 (-57.72%)

32.27 (144.22%)

13.21 (-42.51%)

22.98 (133.31%)

Price to Sales Ratio (P/S)

2.3 (-39.56%)

3.81 (-3.74%)

3.96 (21.43%)

3.26 (11.16%)

Price to Book Ratio (P/B)

1.33 (-47.40%)

2.53 (-14.85%)

2.98 (-7.98%)

3.23 (-8.15%)

Debt to Equity Ratio (D/E)

0.68 (-16.71%)

0.81 (-2.28%)

0.83 (-29.76%)

1.19 (-8.91%)

Earnings Per Share (EPS)

11.21 (39.78%)

8.02 (-61.74%)

20.96 (100.77%)

10.44 (-58.00%)

Sales Per Share (SPS)

66.45 (-2.23%)

67.97 (-2.92%)

70.02 (-4.94%)

73.65 (-11.86%)

Free Cash Flow Per Share (FCFPS)

17.89 (109.45%)

8.54 (-28.01%)

11.86 (-47.40%)

22.55 (-3.30%)

Book Value Per Share (BVPS)

114.81 (12.25%)

102.28 (10.92%)

92.21 (26.18%)

73.08 (9.89%)

Tangible Assets Book Value Per Share (TABVPS)

81.59 (-3.73%)

84.75 (-27.38%)

116.69 (9.46%)

106.61 (8.75%)

Enterprise Value Over EBIT (EV/EBIT)

14 (-57.58%)

33 (175.00%)

12 (-53.85%)

26 (188.89%)

Enterprise Value Over EBITDA (EV/EBITDA)

10.32 (-56.94%)

23.96 (141.54%)

9.92 (-34.56%)

15.16 (98.22%)

Asset Turnover

0.35 (-5.87%)

0.38 (-9.64%)

0.41 (-9.39%)

0.46 (-13.75%)

Current Ratio

1.35 (-32.45%)

2 (-33.26%)

2.99 (63.68%)

1.83 (-0.65%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

$2,604,300,000 (110.74%)

$1,235,800,000 (-28.31%)

$1,723,700,000 (-48.75%)

$3,363,000,000 (-10.39%)

Enterprise Value (EV)

$27,235,101,473 (-36.55%)

$42,922,584,442 (0.20%)

$42,835,268,796 (3.67%)

$41,319,999,463 (-4.55%)

Earnings Before Tax (EBT)

$1,906,000,000 (47.02%)

$1,296,400,000 (-64.77%)

$3,679,700,000 (128.75%)

$1,608,600,000 (-67.78%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

$2,639,400,000 (47.35%)

$1,791,200,000 (-58.51%)

$4,317,700,000 (58.41%)

$2,725,600,000 (-51.84%)

Invested Capital

$10,605,700,000 (-29.84%)

$15,116,600,000 (-10.43%)

$16,876,900,000 (-0.37%)

$16,938,800,000 (-8.57%)

Working Capital

$1,928,000,000 (-43.71%)

$3,425,000,000 (-47.46%)

$6,518,400,000 (83.19%)

$3,558,300,000 (13.15%)

Tangible Asset Value

$11,879,200,000 (-3.13%)

$12,262,600,000 (-27.68%)

$16,955,000,000 (6.67%)

$15,894,900,000 (0.78%)

Market Capitalization

$22,283,401,473 (-40.57%)

$37,495,284,442 (-5.97%)

$39,876,868,796 (13.15%)

$35,242,499,463 (-6.47%)

Average Equity

$16,044,250,000 (11.52%)

$14,386,675,000 (16.76%)

$12,322,050,000 (15.27%)

$10,690,050,000 (-5.64%)

Average Assets

$27,433,550,000 (4.72%)

$26,198,300,000 (6.82%)

$24,526,025,000 (2.18%)

$24,002,275,000 (-5.11%)

Invested Capital Average

$12,711,350,000 (-22.61%)

$16,426,000,000 (-3.02%)

$16,938,375,000 (-5.63%)

$17,949,225,000 (1.66%)

Shares

145,719,340 (0.57%)

144,898,112 (0.62%)

144,001,404 (-1.97%)

146,892,712 (-4.54%)